379 related articles for article (PubMed ID: 9312026)
1. An alternative pathway for gene regulation by Myc.
Peukert K; Staller P; Schneider A; Carmichael G; Hänel F; Eilers M
EMBO J; 1997 Sep; 16(18):5672-86. PubMed ID: 9312026
[TBL] [Abstract][Full Text] [Related]
2. Repression of p15INK4b expression by Myc through association with Miz-1.
Staller P; Peukert K; Kiermaier A; Seoane J; Lukas J; Karsunky H; Möröy T; Bartek J; Massagué J; Hänel F; Eilers M
Nat Cell Biol; 2001 Apr; 3(4):392-9. PubMed ID: 11283613
[TBL] [Abstract][Full Text] [Related]
3. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.
Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG
Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156
[TBL] [Abstract][Full Text] [Related]
4. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
5. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b.
Seoane J; Pouponnot C; Staller P; Schader M; Eilers M; Massagué J
Nat Cell Biol; 2001 Apr; 3(4):400-8. PubMed ID: 11283614
[TBL] [Abstract][Full Text] [Related]
6. Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc.
Kime L; Wright SC
Biochem J; 2003 Feb; 370(Pt 1):291-8. PubMed ID: 12418961
[TBL] [Abstract][Full Text] [Related]
7. Association of Myc with the zinc-finger protein Miz-1 defines a novel pathway for gene regulation by Myc.
Schneider A; Peukert K; Eilers M; Hänel F
Curr Top Microbiol Immunol; 1997; 224():137-46. PubMed ID: 9308237
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of the mammalian UV response by Myc through association with Miz-1.
Herold S; Wanzel M; Beuger V; Frohme C; Beul D; Hillukkala T; Syvaoja J; Saluz HP; Haenel F; Eilers M
Mol Cell; 2002 Sep; 10(3):509-21. PubMed ID: 12408820
[TBL] [Abstract][Full Text] [Related]
10. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
11. Miz-1 and Max compete to engage c-Myc: implication for the mechanism of inhibition of c-Myc transcriptional activity by Miz-1.
Bédard M; Maltais L; Montagne M; Lavigne P
Proteins; 2017 Feb; 85(2):199-206. PubMed ID: 27859590
[TBL] [Abstract][Full Text] [Related]
12. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
13. c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs.
Tobias KE; Shor J; Kahana C
Oncogene; 1995 Nov; 11(9):1721-7. PubMed ID: 7478599
[TBL] [Abstract][Full Text] [Related]
14. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
Rao G; Alland L; Guida P; Schreiber-Agus N; Chen K; Chin L; Rochelle JM; Seldin MF; Skoultchi AI; DePinho RA
Oncogene; 1996 Mar; 12(5):1165-72. PubMed ID: 8649810
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
[TBL] [Abstract][Full Text] [Related]
16. Lack of transcriptional repression by max homodimers.
Yin X; Grove L; Prochownik EV
Oncogene; 1998 May; 16(20):2629-37. PubMed ID: 9632139
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional repression by the proto-oncogene BCL-6.
Seyfert VL; Allman D; He Y; Staudt LM
Oncogene; 1996 Jun; 12(11):2331-42. PubMed ID: 8649773
[TBL] [Abstract][Full Text] [Related]
18. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II.
Bousset K; Oelgeschläger MH; Henriksson M; Schreek S; Burkhardt H; Litchfield DW; Lüscher-Firzlaff JM; Lüscher B
Cell Mol Biol Res; 1994; 40(5-6):501-11. PubMed ID: 7735324
[TBL] [Abstract][Full Text] [Related]
19. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
20. ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation.
Miao L; Song Z; Jin L; Zhu YM; Wen LP; Wu M
Oncogene; 2010 Feb; 29(5):711-22. PubMed ID: 19901969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
